| API | Therapeutic Area | Spec. | Polymorphic Form | CTD | Batch Size | GMP |
|---|---|---|---|---|---|---|
| Dasatinib | Anticancer | In-house | N-6 | JMF | 5Kg | KGMP |
| Fexofenadine HCl | Antihistamines | USP + In-house | Type I | JMF | 400Kg | KGMP/PMDA |
| Alacepril | Cardiovascular | JP | - | JMF | 150Kg | KGMP/PMDA |
| Fimasartan potassium 3H2O | Cardiovascular | In-house | - | NMD | 300Kg | KGMP/EUGMP |
| Pitavastatin Ca | Cardiovascular | JP | Modified Type A | JMF | 35Kg | KGMP/PMDA |
| Aripiprazole | Nervous system | In-house | Type II | JMF | 20Kg | KGMP/PMDA |
| Tamsulosin HCl | Urology | EP | - | JMF | 6Kg | KGMP/PMDA |
PRODUCTS
A guide to all Boryung' products.
-
Kanarb [Fimasartan] (Oral Solid, Filmcoated Tablet)
- Strength
- 60mg, 120mg
- Indication
- Angiotensin II Receptor Blocker
- Shelf Life
- 36
- Packaging Sizes
- 30tabs
Kanarb Plus [Fimasartan 60mg Hydrochlorothiazide (USP), Fimasartan 120mg Hydrochlorothiazide (USP) 12.50 mg 12.50 mg,] (Oral Solid, Filmcoated Tablet)
- Indication
- Angiotensin II Receptor Blocker
- Shelf Life
- 36
- Packaging Sizes
- 30tabs
Dukarb [Fimasartan 60 mg Amlodipine(EP) 5mg, Fimasartan 60 mg Amlodipine(EP) 10mg] (Oral Solid, Filmcoated Tablet)
- Indication
- Angiotensin II Receptor Blocker
- Shelf Life
- 24
- Packaging Sizes
- 30tabs
Dukaro [Fimasartan+Amlodipine+Rosuvastatin (Oral Solid, Filmcoated Tablet) ]
- Strength
- 30/5/5mg, 30/5/10mg, 60/5/5mg, 60/5/10mg
- Indication
- Angiotensin II Receptor Blocker
- Shelf Life
- 30M
- Packaging Sizes
- 30 Tabs
Akarb [Fimasartan+ Atorvastatin (Oral Solid, Filmcoated Tablet) ]
- Strength
- 30/10mg, 30/20mg, 60/10mg, 60/20mg
- Indication
- Angiotensin II Receptor Blocker
- Shelf Life
- 36M
- Packaging Sizes
- 30 Tabs
-
V.C.S Inj. [Vincristine Sulphate ]
- Strength
- 1mg, 2mg
- Indication
- Anticancer
- Shelf Life
- 24M
- Packaging Sizes
- 1 Vial
Velkin Inj. [Bortezomib trimer ]
- Strength
- 2.5mg, 3.5mg
- Indication
- Anticancer
- Shelf Life
- 36M
- Packaging Sizes
- 1 Vial
Alimxid Inj. [Pemetrexed disodium 2.5 hydrate ]
- Strength
- 500mg
- Indication
- Anticancer
- Shelf Life
- 36M
- Packaging Sizes
- 1 Vial
Effcil Inj. [5 Fluorouracil ]
- Strength
- 500mg
- Indication
- Anticancer
- Shelf Life
- 24M
- Packaging Sizes
- 10 Vials
Oxalitin [Oxaliplatin] (inj)
- Strength
- 50mg,100mg
- Indication
- Anticancer
- Shelf Life
- 36,24
Neoplatin [Carboplatin] (inj)
- Strength
- 150mg, 450mg
- Indication
- Anticancer
- Shelf Life
- 24
EP mycin [Epriubicin] (inj)
- Strength
- 10mg,50mg
- Indication
- Anticancer
- Shelf Life
- 36
AD mycin [Doxorubicin] (inj)
- Strength
- 10mg,50mg
- Indication
- Anticancer
- Shelf Life
- 24
-
GelfosM [ALPO4, Mg Hydroxide, Simethicone] (sachet)
- Strength
- 20g/sachet X 4s
- Indication
- Hypergastric acidity, heartburn, gastric and duodenal ulcer, gastritis, gastralgia, nausea
- Shelf Life
- 24
- Packaging Sizes
- 4sachets/Box
-
Marketed API
Pipeline API
Pipeline API API Therapeutic Area Filing Status Olaparib Anticancer Lab scale development until 2021 Ezalutamide Anticancer Lab scale development until 2021 Edoxaban Anticoagulant Pilot batch planned 2021 Pilsicainide Cardiovascular PV batch planned 3Q, 2021 Cilnidipine Cardiovascular PV completed Lafutidine Gastrointestinal PV completed Dapagliflozin Metabolism Pilot batch planned 3Q, 2021 Empagliflozin Metabolism Lab scale development until 2021 Brexpiprazole Nervous system Pilot batch planned 2022